Old Web
English
Sign In
Acemap
>
authorDetail
>
Simona Duranti
Simona Duranti
Yahoo!
Medicine
Lung cancer
KRAS
Gefitinib
Pathology
5
Papers
108
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion Gene
2014
Journal of Clinical Oncology
Rita Chiari
Simona Duranti
Ludovini
Guido Bellezza
Anjuta Pireddu
Minotti
Chiara Bennati
Lucio Crinò
Show All
Source
Cite
Save
Citations (32)
Emerging drugs for small cell lung cancer – an update
2012
Expert Opinion on Emerging Drugs
Giulio Metro
Simona Duranti
Matthias Joachim Fischer
Federico Cappuzzo
Lucio Crinò
Show All
Source
Cite
Save
Citations (17)
KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts).
2012
Journal of Clinical Oncology
Giulio Metro
Simona Duranti
Rita Chiari
Chiara Bennati
Carmen Molica
Maria Francesca Currà
Chiara Scafati
Annamaria Siggillino
A. Flacco
Luca Marcomigni
Vienna Ludovini
Vincenzo Minotti
Lucio Crinò
Show All
Source
Cite
Save
Citations (2)
1